Navigation Links
Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008
Date:2/29/2008

al evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. The third clinical stage antibody is MT293 (TRC093), a first-in-class humanized monoclonal antibody that inhibits angiogenesis and tumor cell growth by binding cleaved collagen. MT293 is licensed to TRACON Pharmaceuticals, Inc. and is being developed in a phase 1 clinical trial for the treatment of patients with cancer and age-related macular degeneration. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, Micromet's human antibody neutralizing the activity of GM-CSF, which has potential applications in the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as autoimmune diseases.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Micromet to Present at Two Upcoming Investor Conferences
2. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
3. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
4. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
5. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
6. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
7. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
8. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
9. NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
10. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
11. Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...tochromatodayannouncedtheappointmentofPeterMoldt,P...kSporkastheNovoA/SrepresentativeontheCompany,sBoar...ers. ,, "WeareverypleasedtowelcomePeterMoldttot...andguidanceasCytochromacontinuestomakeprogressinbe...mpany,"statedAlanLewis,PhD,ChairmanofCytochroma,sB...
(Date:11/24/2009).... , Whether it,s CD packaging, containers or...Identification) are increasingly finding their way...l objects or goods and identify them automatically...ead and process the data contained in the label. S...on conditions of up to 100 degrees Celsius. But at...
(Date:11/24/2009)...re/--TwomoreprestigiousuniversitieshavejoinedBioCa...erssiteforlifescienceprofessionals. ,, Northwes...d,joining28othermajorlifesciencetrainingInstitutio...onlyforpost-graduatesinthelifesciences.Whiletherea...oCareerCenteristheonlyonethatserveslifesciencepost...
(Date:11/24/2009)...mployment grew by 29,000 jobs in October, and the...wth during the U.S. recession. However, clinics an...h systems are coming closer to having to actually ...ors. , (Vocus) November 2...g in October despite the shedding of jobs in most ...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...,s Structure-Based Drug Discovery Capabilities, I...Company (NYSE: LLY ) and SGX Pharmaceuticals, Inc...ies have signed a definitive merger agreement,prov...ansaction. SGX, based,in San Diego, California, is... and development in the area of oncology. Under th...
..., July 8 Biotech and pharmaceutical,firms are dev...eamline the,complicated drug discovery process, re...GEN). Most successful approaches rely on a combina...rization techniques, and,advanced data-analysis to...ttp://www.genengnews.com/articles/chitem.aspx?aid=...
...nanomedical applications in diagnostics, imaging, ...EVELAND, July 8 The Nano-Network, Cleveland Clini...rve University today,announced the organizations w...he use of nanoparticles for diagnostics, imaging a...atient care., The 2008 NanoMedicine Summit will t...
Other Biology Technology:Lilly to Acquire SGX Pharmaceuticals 2Lilly to Acquire SGX Pharmaceuticals 3Lilly to Acquire SGX Pharmaceuticals 4Lilly to Acquire SGX Pharmaceuticals 5GEN Reports on Novel Hit-to-Lead Drug Discovery Strategies 2NanoMedicine Summit Returns to Cleveland, September 25-26 2NanoMedicine Summit Returns to Cleveland, September 25-26 3NanoMedicine Summit Returns to Cleveland, September 25-26 4
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
Breaking Biology News(10 mins):A coating for life 2Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Geneticists coordinate action to fight against traffic in human beings 10675 1Geneticists coordinate action to fight against traffic in human beings 10675 2Geneticists coordinate action to fight against traffic in human beings 10675 3Noted entomologist to receive science excellence award 10672 1Noted entomologist to receive science excellence award 10672 2Noted entomologist to receive science excellence award 10672 3Common Infections May Contribute to Strokes 61075 1Common Infections May Contribute to Strokes 61075 2Common Infections May Contribute to Strokes 61075 3
...ing blocks of life--is exploding as scientists wor...th, disease and the development of organisms. The ...need for researchers to develop a shared vocabular...ing their findings. , An international team of RNA... has now been formed to do just that. , "The cons...
...gy (IBN) has developed a novel method to simultane...cles, which can be used in pharmaceutical synthesi...dbreaking research was recently featured in the le...United States patent has been filed on the inventi...ive Director Prof. Jackie Y. Ying have developed a...
...ed an automated literature search tool for the mul...ol is available as a free plug-in to Cytoscape 2.1...les researchers to form a visual map of complex bi...of molecular pathways and the biological causes of...omatically searches for and extracts information f...
Other Biology News:RNA project to create language for scientists worldwide 2RNA project to create language for scientists worldwide 3Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications 2Agilent Technologies releases automated literature search tool for biology researchers 2Agilent Technologies releases automated literature search tool for biology researchers 3
pRSET-E Echo Expression Vector Kit from Invitrogen
arrayWoRxe from Applied Precision, LLC
TopSpot E non-contact microarrayer from Parallabs
LabCD ADMET System from Tecan
Biology Products: